Related Experiment Video
Updated: Jun 6, 2026
12:24
Murine Model of CD40-activation of B cells
Published on: March 5, 2010
Signaling through OX40 enhances antitumor immunity
Shawn M Jensen1, Levi D Maston, Michael J Gough
1Robert W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Providence Cancer Center, Providence Portland Medical Center, Portland, OR 97213, USA. shawn.jensen@providence.org
Seminars in Oncology
|November 16, 2010
Summary
harnessing the immune system to fight cancer is possible, but challenges remain. The OX40 signaling pathway shows promise for enhancing anti-tumor immunity, especially when combined with strategies that prime tumor-specific T cells.
Area of Science:
- Immunology
- Cancer Biology
- Molecular Medicine
Background:
- The immune system can target cancer, but often fails within the tumor microenvironment.
- Tumor necrosis factor (TNF) superfamily members, like OX40 and OX40L, regulate T-cell responses.
- OX40 signaling influences T-cell expansion, survival, cytokine production, and regulatory T-cell function.
Purpose of the Study:
- To explore strategies for converting ineffective anti-tumor immune responses into sustained tumor destruction.
- To evaluate the potential of OX40 agonists in enhancing anti-tumor immunity.
- To investigate combining OX40 signaling with T-cell priming strategies for improved cancer therapy.
Main Methods:
- Review of preclinical studies on OX40 agonists in cancer models.
- Analysis of OX40 signaling's role in T-cell mediated immunity.
- Exploration of combination strategies for cancer immunotherapy.
Main Results:
- OX40 agonists have shown efficacy in enhancing anti-tumor immunity in preclinical models with immunogenic tumors.
- The success of OX40 agonists has been limited in poorly immunogenic tumors.
- OX40 signaling modulates key aspects of T-cell function relevant to cancer immunity.
Conclusions:
- Effective cancer immunotherapy requires overcoming obstacles within the tumor microenvironment.
- OX40 agonists represent a promising therapeutic target for augmenting anti-tumor immune responses.
- Combining T-cell priming with OX40 signaling may offer a synergistic approach for sustained cancer destruction.
Related Concept Videos
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:17The Extrinsic Apoptotic Pathway
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
01:19Interactions Between Signaling Pathways
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
01:26Signal Transduction: Overview
Cells respond to many types of information, often through receptor proteins positioned on the membrane. They respond to chemical signals, such as hormones, neurotransmitters, and other signaling molecules, initiating a series of molecular reactions to produce an appropriate response. This is called signal transduction. Cells also coordinate different responses elicited by the same signaling molecule via mediators, allowing molecular cross-talk.
Typically, signal transduction involves three...
Typically, signal transduction involves three...
01:27Cytotoxic T Cells-mediated Immune Response
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...